Recent Quotes (30 days)
You have no recent quotes
| BABA | 84.74 | -1.41-1.63% |  |
| 3699 | 49.75 | +1.553.22% | |
| 000830 | 59,100.00 | +100.000.00% | |
| INTC | 31.71 | +0.4701.50% | |
| UA | 83.61 | -0.580-0.69% | |
| 2498 | 133.50 | -1.50-1.11% | |
| NVDA | 22.52 | -0.005-0.02% | |
| 005935 | 1,161,000.00 | +12,000.001.00% | |
| HPQ | 31.52 | -0.035-0.11% | |
| QCOM | 68.90 | +0.0900.13% | |
| 2454 | 421.50 | -0.500-0.12% | |
| AAPL | 126.86 | +0.3000.24% | |
| BARC | 256.50 | -1.45-0.56% | |
| YHOO | 45.25 | -0.380-0.83% | |
| 066570 | 59,100.00 | -100.000.00% | |
| SNE | 30.48 | +0.5801.94% | |
| 0992 | 12.88 | +0.1401.10% | |
| 0700 | 161.80 | +1.901.19% | |
| 000001 | 19.80 | +1.8010.00% | |
| 601318 | 86.14 | +4.705.77% | |
12.61
+0.01
(0.08%)
Real-time:
11:09AM EDT
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 12.37 - 12.62 |
| 52 week | 8.32 - 12.62 |
| Open | 12.54 |
| Vol / Avg. | 19,297.00/225,102.00 |
| Mkt cap | 463.62M |
| P/E | - |
| Div/yield | - |
| EPS | -0.14 |
| Shares | 36.77M |
| Beta | 1.16 |
| Inst. own | 71% |
Events
May 13, 2015
Q1 2015 Syneron Medical Ltd Earnings Release (Estimated)
Mar 12, 2015
Syneron Medical Ltd at Barclays Healthcare Conference
Feb 18, 2015
Q4 2014 Syneron Medical Ltd Earnings Release
Feb 18, 2015
Q4 2014 Syneron Medical Ltd Earnings Call -
Feb 12, 2015
Syneron Medical Ltd at Leerink Global Healthcare Conference -
|
More events from DailyFinance »
|
Key stats and ratios
| Q4 (Dec '14) | 2014 | |
| Net profit margin | -1.85% | -2.03% |
| Operating margin | -0.23% | -0.87% |
| EBITD margin | - | 2.78% |
| Return on average assets | -1.79% | -1.70% |
| Return on average equity | -2.39% | -2.26% |
| Employees | 659 | - |
| CDP Score | - | - |
Address
Tavor Building 4 P.O. Box 550
YOKNEAM, 2069200
Israel
+972-7-32442200 (Phone)
+972-7-32442202 (Fax)
YOKNEAM, 2069200
Israel
+972-7-32442200 (Phone)
+972-7-32442202 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Volume delayed by 15 mins.
Advertisement
Description
Syneron Medical Ltd. is an aesthetic device company. The Company's technology enables physicians to provide solutions for a range of medical-aesthetic applications, including body contouring, hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch. The Company’s product include Alex TriVantage, eLase with Motif, eLaser,elight, elos Plus andePrime, among others. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch.
Officers and directors
| Shimon Eckhouse Ph.D. | Chairman of the Board | |
| Amit Meridor | Chief Executive Officer | |
| Hugo Goldman | Chief Financial Officer | |
| William Griffing | Chief Executive Officer - Syneron Candela North America | |
| Dominick A. Arena | Director | |
| Stephen J. Fanning | Director | |
| David Schlachet | Director | |
| Michael J. Anghel | External Independent Director | |
| Yaffa Krindel | Independent Director |